Lilly Novo Nordisk Battle Intensifies as Obesity Drugs Surge
Eli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
Understand when to choose long term vs short term investments. Make strategic decisions that align with your goals.
27,010 articlesEli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
Nvidia remains modestly below its peak as data-center momentum sustains growth. Analysts say the pullback could offer...
A prominent investor labels SpaceX’s lofty value as bubblicious, arguing that Starlink’s progress alone may not justi...
The S&P 500 trades at 22x forward earnings, but a deeper look at cash flow reveals a 32x multiple, driven by AI-relat...
Dive into how to read myriad genetics (mygn) 2025 earnings transcripts, spot growth drivers, assess risk, and build a...
The USDA forecasts a narrower agricultural trade deficit for FY2026, signaling policy momentum as farm markets stabil...
XRP remains range-bound around $1.40 as Bitcoin stalls below $75,000. Traders say the price can’t break until BTC cle...
Fastly stock jumps 11% after a strong Q4 2025 report, fueling talk of a true comeback. Yet persistent insider selling...
Strategy reported a $12.54 billion Q1 loss driven by unrealized BTC declines, even as its software business expanded ...
Citi sees the recent aerospace pullback as a rare entry point for Boeing, lifting the target to $260 and signaling a ...
Prediction markets show the CLARITY Act odds collapsing from 75% to 50% in a single week, underscoring growing doubt ...
Fed Chair Kevin Warsh grapples with President Trump's pressure to slash rates, a stance that could influence Social S...